Anthropic appoints Novartis CEO Vas Narasimhan to Board - The Economic Times

AI major Anthropic has appointed Vas Narasimhan to its Board of Directors, in a move that further elevates the company's emphasis on responsible deployment of advanced artificial intelligence (AI) in healthcare and life sciences.

The appointment was made by Anthropic's independent Long-Term Benefit Trust, a governance body designed to preserve alignment between the company's commercial success and its public-benefit mission of ensuring AI is developed for the long-term benefit of humanity.

Narasimhan is the chief executive officer of Novartis, one of the world's largest and most influential innovative medicines companies, where he has overseen the development and regulatory approval of more than 35 novel therapies.

"Vas brings something rare to our board," said Daniela Amodei, cofounder and President of Anthropic in a blog post. "Getting powerful new technology to people safely and at scale is what we think about every day at Anthropic. Vas has been doing exactly that for years."